OrbiMed

OrbiMed is a leading investment firm dedicated exclusively to the life sciences sector, with approximately $6 billion in assets under management. OrbiMed invests across the entire spectrum of pharmaceutical, biotechnology and medical device companies on a worldwide basis. Investments are made through venture capital funds, public equity funds, and other investment vehicles. Since inception of its venture capital activities in 1993, OrbiMed has partnered with over 100 companies across a wide range of therapeutic categories and stages of development. OrbiMed’s investment team includes over 40 experienced investment professionals with offices in New York City, Tel Aviv, San Francisco, Shanghai and Mumbai. Recently OrbiMed launched OrbiMed Israel Partners Limited Partnership, a $222 million fund dedicated to Israeli life science investments. As the largest investment firm dedicated to the healthcare sector by net assets under management, OrbiMed seeks to be a capital provider of choice, bringing the global resources required to be an exceptional long term partner for building world-class biopharmaceutical and medical technology companies.

GE Ventures

GE Ventures combines capital, technical and commercial expertise to scale great ideas that drive growth for partners and GE. Focused on the areas of software, healthcare, advanced manufacturing and energy, GE Ventures helps entrepreneurs and startups accelerate their ideas by providing access to GE’s global network of business, customers and partners. Offering a tailored approach and unparalleled resources through its Global Research Center, GE Ventures helps reduce development cycles and accelerate time to market for entrepreneurs and companies.

Gilo Ventures II

Gilo Ventures is a venture capital firm that seeks companies positioned for high growth technology markets with a US $1+ billion market potential. It prefers to invest in companies with proprietary technology. It also considers companies that possess first mover advantage and the potential to capture significant market share quickly. Gilo Ventures focus primarily on technologies and services for carrying and managing broadband communication over various platforms including fiber optics, wireless, copper. Its investments typically range in size from US $250,000 to $20 million.

Agate Medical Investments

Agate Medical Investments LP is a group of funds founded by Dani Naveh, specialized in providing growth capital to mature Medtech companies. Agate, as one of Israel’s leading healthcare investors, has established a leading position in the healthcare VC industry, resulting in quality deal-flow and investor partnerships. Since its formation in late 2007, Agate I has invested in 9 promising companies. Agate II was established in February 2012, for Korea-Israel MedTech investments, under partnership in the MAC fund.